Chie Morimoto

3PUBLICATIONS
7CO-AUTHORS
Gene and molecular therapyBehavioural epidemiologyAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 07, 2021
Gastroesophageal reflux disease is a risk factor for sputum production in the general population: the Nagahama study.

Chie Morimoto, Hisako Matsumoto, Tadao Nagasaki

|May 08, 2020
High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study.

Chie Morimoto, Hisako Matsumoto, Tomoko Tajiri

Pageof 1